Synergistic hepatoprotective effect of Schisandrae lignans with Astragalus polysaccharides on chronic liver injury in rats

Phytomedicine - Tập 16 - Trang 805-813 - 2009
Fei Yan1, Qiao-Yan Zhang1, Lei Jiao1, Ting Han1, Hong Zhang1, Lu-Ping Qin1, Rahman Khalid2
1Department of Pharmacognosy, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
2Faculty of Sciences, School of Biomolecular Sciences, Liverpool John Moores University, Liverpool L33AF, UK

Tài liệu tham khảo

Adrian, Y.S., Yip, Wings, T.Y., Loo, Louis, W.C., Chow, 2007. Fructus Schisandrae (Wuweizi) containing compound in modulating human lymphatic system – a Phase I minimization clinical trial. Biomedicine & Pharmacotherapy 61, 588–590. Bockhold, 2005, Overcoming obstacles to immunization in patients with chronic liver disease, The American Journal of Medicine, 118, 40, 10.1016/j.amjmed.2005.07.015 Brattin, 1985, Pathological mechanisms in carbon tetrachloride hepatotoxicity, Journal of Free Radicals in Biology & Medicine, 1, 27, 10.1016/0748-5514(85)90026-1 Cao, 1989, Potentiation of antimetabolite antitumor activity in vivo bydipyridamole and amphotericin B, Cancer Chemotherapy and Pharmacology, 24, 181, 10.1007/BF00300240 Cheeseman, 1995, Free radicals and liver injury, Immunopharmacology of Free Radical Species, 233, 10.1016/B978-012103520-4/50017-9 EISisi, 1993, Vitamin A potentiation of carbon tetrachloride hepatoxicity: role of liver macrophages and active oxygen species, Toxicology and Applied Pharmacology, 119, 295, 10.1006/taap.1993.1072 Feng, 2006, The study on processing of schizandra chinensis yoghurt, Food Industry, 27, 45 Guo, 2006, Research progress on the pharmacological study of Fructus Schisandrae chinensis, Acta Chinese Medicine and Pharmacology, 34, 51 Li, 2005, Overview on active component and its pharmacologic action of Fructus Schisandrae chinensis, Journal of Chinese Medicinal Materials, 28, 156 Li, 2005, Study on chemical and immunologic of Astragalus polysaccharide, Shanghai Journal of Animal Husbandry and Veterinary Medicine, 5, 4 Li, 2006, Establishment and evaluation of experimental liver injury animal model, Radiologic Practice, 21, 1075 Loo, 2007, Fructus schisandrae (Wuweizi)-containing compound inhibits secretion of HBsAg and HBeAg in hepatocellular carcinoma cell line, Biomedicine & Pharmacotherapy, 61, 606, 10.1016/j.biopha.2007.08.023 Mates, 1999, Antioxidant enzymes and human diseases, Clinical Biochemistry, 32, 595, 10.1016/S0009-9120(99)00075-2 Mei, 2007, Suppression of immune-mediated liver injury after vaccination with attenuated pathogenic cells, Immunology Letters, 110, 29, 10.1016/j.imlet.2007.02.008 Nelson Fausto, 2006, Involvement of the innate immune system in liver regeneration and injury, Journal of Hepatology, 45, 347, 10.1016/j.jhep.2006.06.009 Ohkawa, 1979, Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction, Analytical Biochemistry, 95, 351, 10.1016/0003-2697(79)90738-3 Recnagal, 1983, A new direction in the study of carbon tetrachloride hepatotoxicity, Life Science, 33, 401, 10.1016/0024-3205(83)90787-7 Schepetkin, 2006, Botanical polysaccharides: macrophage immunomodulation and therapeutic potential, International Immunopharmacology, 6, 317, 10.1016/j.intimp.2005.10.005 Shan, 2000, Progress of chemical and pharmacological study of Astragalus polysaccharide, Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai, 14, 61 Shao, 2004, A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb, Biochemical and Biophysical Research Communications, 320, 1103, 10.1016/j.bbrc.2004.06.065 Shen, 2005, Pharmacological activities of lignans in kadsura and clinical application of kadsara, Academic Journal of Kunming Medical College, 1, 102 Sheweita, 2001, Carbon tetrachloride changes the activity of cytochrome P450 system in the liver of male rats: role of antioxidants, Toxicology, 169, 83, 10.1016/S0300-483X(01)00473-5 Stickel, 2007, Herbal medicine in the treatment of liver diseases, Digestive and Liver Disease, 39, 293, 10.1016/j.dld.2006.11.004 Strader, 2002, Use of complementary and alternative medicine in patients with liver disease, The American Journal of Gastroenterology, 97, 2391, 10.1111/j.1572-0241.2002.05993.x Tian, 2008, Research and development of Schisandra chinensis win, China Brewing, 88 Ulrich-Merzenich, 2007, Application of the Omic-technologies in phytomedicine, Phytomedicine, 14, 76, 10.1016/j.phymed.2006.11.011 Wan, 2008, Synergistic effect of paeonol and cisplatin on oesophageal cancer cell lines, Digestive and Liver Disease, 40, 531, 10.1016/j.dld.2008.01.012 Williamson, 2001, Synergy and other interactions in phytomedicine, Phytomedicine, 8, 400, 10.1078/0944-7113-00060 Xu, 2008, Mechanisms of drug-induced liver injury, Medical Recapitulate, 14, 747 Yang, 2003, Research on fructus schisandrae chinensis, West China Pharmacy Magazine, 18, 438 Zhang, 2002, Deoxyschizandrin and schizandrin protect liver against carbon tetradfloride induced damage, Medical Journal of the Chinese People's Armed Police Forces, 13, 395 Zimmermann, 1973, Inhibition of lipid peroxidation in isolated inner membrane of rat liver mitochondria by superoxide dismutase, Febs Letters, 29, 117, 10.1016/0014-5793(73)80539-3